×
Close
註冊
登入
主页
用户
博客
照片
视频
医学图书S馆
医学图书M馆
医学图书D馆
医学术语
群组
活动
用户工具
用户指南
问答
谁看过我
反馈
语言
English
中文
推广
×
Close
More from this channel
Comparative efficacy studies of biosimilars: data versus theoretical risks, beliefs, and comfort
Budget impact analysis of a rituximab intravenous biosimilar in patients with follicular lymphoma and large B-cell non-Hodgkin lymphoma in Chile
Current understanding, knowledge, and perception of biosimilars in a changing landscape of regulatory requirements
Infliximab discontinuation in patients with originator retransition vs. biosimilar continuation
Pharmacokinetic bioequivalence studies of a new Etoricoxib tablet formulation developed using proprietary MiST technology — risk assessment and mitigation using GastroPlus software
Switches between biosimilars and their reference products
Latest features in GaBI Journal, 2023, Issue 3
Trends in Saudi FDA drug approvals and GMP inspections: an observational study
The incorporation of the Halal Management System (HMS) by the pharmaceutical industry
Biosimilar antibody drug conjugates: considerations of higher order structure and aggregation
Sourcing innovator products in the age of biosimilar research
Sourcing innovator products in the age of biosimilar research Published in:
Volume 4 / Year 2015 / Issue 2
Category:
Sponsored Article
Author(s):
Michael Cohan
Visits: 32 total, 32 today
Keywords: Innovator drug sourcing challenges
View original article
GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL
thumb_up
Like
share
分享
favorite
书签
0
0
0
0
0
0
0
留言 (
0
)
gif
登入或註冊以發表你的留言
Modal title
×
Modal title
×
分享
登入
Global News and Health Forum
Join Now!
馬上登入
記住我
忘記密碼?
或者使用
Linkedin
留言 (0)